Abstract: . . .  [The Health and Labor Questionnaire]. Int J Technol Assess Health Care 1996;12:405-15 25. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4:35365 26. Endicott J, Nee J. Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacol Bull 1997;33:13-6 27. Koopman C, Pelletier KR, Murray JF, et al. Stanford presenteeism . . .
. . .  allergic rhinitis : impact on symptoms, quality of life, productivity, and activity impairment. Allergy Asthma Proc 2002;23:391-8 15. Ross RN. The costs of allergic rhinitis . Am J Managed Care 1996;2:285-90 16. Corren J. The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol 1998;101:S352-S356 17. WelshPW,StrickerWE,ChuCP,etal.Efficacyofbeclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. . . .
. . .  2001;43:218-25 10. Burton WN, Conti DJ, Chen CY, et al. The impact of allergies and allergy treatment on worker productivity. J Occup Environ Med 2001;43:64-71 11. Kessler RC, Barber C, Birnbaum HG, et al. Depression in the workplace: effects on short-term disability. Health Affairs1999;18:163-71 12. Ozminkowski RJ, Goetzel RZ, Long SR. A validity analysis of the work productivity short inventory (WPSI) instrument measuring employee health and productivity. . . .
. . .  Nee J. Endicott Work Productivity Scale (EWPS): a new measure to assess treatment effects. Psychopharmacol Bull 1997;33:13-6 27. Koopman C, Pelletier KR, Murray JF, et al. Stanford presenteeism scale: health status and employee productivity. J Occup Environ Med 2002;44:14-20 28. Stewart WF, Lipton RB, Simon D, et al. Validity of an illness severity measure for headache in a population sample of migraine sufferers. Pain 1999;79:291-301 29. Dawson EG, . . .
. . .  8267 US employees, indirect costs associated with absenteeism and presenteeism due to illness were $2962 per employee per year. Allergic rhinitis , a highly prevalent condition, was associated with a high rate of productivity losses and costs. Payers and employers should consider data from this study when determining health benefits for employees and planning preventive health care intervention strategies. Acknowledgments Funding for this . . .
. . .  Environ Med 2001;43:36-46 21. ClaxtonAJ,ChawlaAJ,KennedyS.Absenteeismamongemployees treated for depression. J Occup Environ Med 1999;41:605-11 22. Burton WN, Conti DJ, Chen CY, et al. The economic burden of lost productivity due to migraine headache: a specific worksite analysis. J Occup Environ Med 2002;44:523-9 23. Lerner D, Amick BCI, Rogers WH, et al. The Work Limitations Questionnaire. Med Care 2001;39:72-85 24. van Roijen L, Essink-Bot ML, Koopmanschap . . .
--3000,6,250,3474,41785